Severin G
J Pharm Sci. 1987 Mar;76(3):231-4. doi: 10.1002/jps.2600760310.
An HPLC methodology is described which enables the quantitation of thiothixene (N,N-dimethyl-9-[3-(4-methyl-1-piperazinyl)-propylidene]thioxanthe ne-2- sulfonamide) in bulk drug, finished product, and dissolution samples using a single analytical column (SiAl: a mixture of silica and alumina). The Z (cis) and the less pharmacologically active E (trans) isomers of thiothixene, as well as synthetic precursors and degradants, are well resolved within a short chromatographic run. A minor modification of the mobile phase allows direct injection and quantitation of low-concentration samples in a simulated gastric fluid (SGF) dissolution medium. The method is capable of supplanting the three separate procedures currently included in the thiothixene monograph of the U.S. Pharmacopeia XXI.
本文描述了一种高效液相色谱法,该方法能够使用单一分析柱(SiAl:硅胶和氧化铝的混合物)对原料药、成品和溶出度样品中的硫利达嗪(N,N - 二甲基 - 9 - [3 - (4 - 甲基 - 1 - 哌嗪基) - 亚丙基]噻吨 - 2 - 磺酰胺)进行定量分析。硫利达嗪的Z(顺式)和药理活性较低的E(反式)异构体,以及合成前体和降解产物,在短时间的色谱运行中能够得到很好的分离。流动相的微小改变允许在模拟胃液(SGF)溶出介质中直接进样并定量低浓度样品。该方法能够取代美国药典 XXI 版硫利达嗪专论中目前包含的三个单独程序。